Answers are grounded in this paper and cite their sources.
Identifies potential therapeutic targets in ischemic stroke, suggesting insights into disease mechanisms.
Mitochondrial DNA methylation (mtDNA-M) is a crucial epigenetic factor in ischemic stroke (IS); however, its specific role in the disease remains poorly characterized. This study aimed to explore MTDM-related key genes and therapeutic targets in IS through bioinformatics, machine learning, and experimental validation. Differentially expressed genes were identified using the GSE16561 dataset, and MTDM-related molecular subtypes of IS were classified via consensus clustering based on MTDM-related genes. We identified 52 candidate genes through the intersection of DEGs across subtypes and cases, from which seven key genes were prioritized through three machine learning algorithms (LASSO, SVM-RFE, and Boruta) to identify the most robust candidates. Among them, CD6, EVL, HIST2H2AA3, and SORL1 showed consistent robust discriminatory power (AUC > 0.7) and were validated using BP neural networks and RT-qPCR in clinical samples. Functional enrichment analysis revealed their involvement in immune-related pathways, particularly in CD8 + T cell infiltration and primary immunodeficiency. Gene co-expression and regulatory network mapping suggested key miRNA (e.g., hsa-miR-26a-5p) and lncRNA (e.g., KCNQ1OT1) interactions, proposing layered transcriptional control. Our findings identify four immune-related genes as potential key genes and therapeutic targets for precision medicine in IS, advancing our understanding of the disease’s epigenetic regulation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: